Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNeviā€™a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: [email protected]

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    37,851

Teva Pharmaceutical Industries Ltd News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,520.1048.600.57%
CAC 407,355.3772.681.00%
DAX 4019,984.32135.550.68%
Dow JONES (US)42,992.21333.59-0.77%
FTSE 1008,149.7812.790.16%
HKSE20,090.467.83-0.04%
NASDAQ19,722.03298.33-1.49%
Nikkei 22540,281.16713.101.80%
NZX 50 Index13,205.10130.361.00%
S&P 5005,970.8466.75-1.11%
S&P/ASX 2008,261.8040.900.50%
SSE Composite Index3,400.142.070.06%

Market Movers